Anil Kumar Kalvala

1.3k citations
29 papers · 1.0k indexed · h-index 18
Topics
Pain Mechanisms and Treatments (6 papers)Sirtuins and Resveratrol in Medicine (6 papers)Cannabis and Cannabinoid Research (6 papers)
Partner nations
IndiaUnited StatesCanada

In The Last Decade

Anil Kumar Kalvala

28 papers receiving 1.0k citations

Peers

Anil Kumar Kalvala
Comparison fields: 5 of 95
  • Molecular Biology 441
  • Physiology 243
  • Pharmacology 195
  • Pharmacology 138
  • Epidemiology 127
Replace Mengen Zhai with:
Mengen Zhai China
Hsiu‐Chung Ou Taiwan
Hong Xu China
Jia Cui China
Mi‐Young Jeong South Korea
Yisong Qian China
Ke Fang China
Xiaofang Fan China
Anil Kumar Kalvala relative to Mengen Zhai China Mengen Zhai's profile →
Citations per field
00.5×1.5×
Mengen Zhai · 1×
Citations per year

Countries citing papers authored by Anil Kumar Kalvala

Since Specialization
Citations

This map shows the geographic impact of Anil Kumar Kalvala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil Kumar Kalvala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil Kumar Kalvala more than expected).

Fields of papers citing papers by Anil Kumar Kalvala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil Kumar Kalvala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil Kumar Kalvala. The network helps show where Anil Kumar Kalvala may publish in the future.

Co-authorship network of co-authors of Anil Kumar Kalvala

This figure shows the co-authorship network connecting the top 25 collaborators of Anil Kumar Kalvala. A scholar is included among the top collaborators of Anil Kumar Kalvala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil Kumar Kalvala. Anil Kumar Kalvala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 18
4 17
5 13
6 10
7 15
8 2
9 16
10 18
11 47
12 10
13 31
14 62
15 28
16 37
17 21
18 94
19 61
20 108

About Anil Kumar Kalvala

Anil Kumar Kalvala is a scholar working on Geriatrics and Gerontology, Pharmacology and Physiology, having authored 29 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (6 papers), Sirtuins and Resveratrol in Medicine (6 papers) and Cannabis and Cannabinoid Research (6 papers). The work is most often cited by research in Geriatrics and Gerontology (107 citations), Pharmacology (138 citations) and Pharmacology (195 citations). Anil Kumar Kalvala has collaborated with scholars based in India, United States and Canada. Frequent co-authors include Ashutosh Kumar, Veera Ganesh Yerra, Bhoomika Sherkhane, Chayanika Gundu, Aparna Areti, Vijay Arruri, Jerald Mahesh Kumar, Ramakrishna Sistla, Bidya Dhar Sahu and Shyam Sunder Rachamalla. Their work appears in journals such as PLoS ONE, The FASEB Journal and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026